Explore more publications!

Latest News

Labels On
FILTER THE FEED
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
FILTER THE FEED
Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Finland, China to deepen mutually beneficial cooperation

Finland, China to deepen mutually beneficial cooperation

Indeterminate Daily Finland
Owner: Ofiul Hasnat (Founder & Editor-In-Chief)
Extreme Heat: Scientists warn 3.8 billion people may be at risk by 2050

Extreme Heat: Scientists warn 3.8 billion people may be at risk by 2050

Pharmacokinetic Model Based on Stochastic Simulation and Estimation for Therapeutic Drug Monitoring of Teicoplanin in Korean Neutropenic Hematopoietic Stem Cell Transplant Recipients

Pharmacokinetic Model Based on Stochastic Simulation and Estimation for Therapeutic Drug Monitoring of Teicoplanin in Korean Neutropenic Hematopoietic Stem Cell Transplant Recipients

Orlen enters into Finnish hydrogen agreements

Orlen enters into Finnish hydrogen agreements

Finland helps crack the oat genome in global research effort

Finland helps crack the oat genome in global research effort

Machine Learning-Based Diagnostic Models for Early Gastric Cancer Using Clinical Laboratory Indicators

Machine Learning-Based Diagnostic Models for Early Gastric Cancer Using Clinical Laboratory Indicators

Finland is trying to poach top tech and AI talent from the US with 2-week visas and better work-life balance

Finland is trying to poach top tech and AI talent from the US with 2-week visas and better work-life balance

Neutral Business Insider
Owner: Mathias Döpfner & Friede Springer
Extreme Heat: Scientists warn 3.8 billion people may be at risk by 2050

Extreme Heat: Scientists warn 3.8 billion people may be at risk by 2050

Pharmacokinetic Model Based on Stochastic Simulation and Estimation for Therapeutic Drug Monitoring of Teicoplanin in Korean Neutropenic Hematopoietic Stem Cell Transplant Recipients

Pharmacokinetic Model Based on Stochastic Simulation and Estimation for Therapeutic Drug Monitoring of Teicoplanin in Korean Neutropenic Hematopoietic Stem Cell Transplant Recipients

Orlen enters into Finnish hydrogen agreements

Orlen enters into Finnish hydrogen agreements

Finland helps crack the oat genome in global research effort

Finland helps crack the oat genome in global research effort

Machine Learning-Based Diagnostic Models for Early Gastric Cancer Using Clinical Laboratory Indicators

Machine Learning-Based Diagnostic Models for Early Gastric Cancer Using Clinical Laboratory Indicators

Finland is trying to poach top tech and AI talent from the US with 2-week visas and better work-life balance

Finland is trying to poach top tech and AI talent from the US with 2-week visas and better work-life balance

Finland, China to deepen mutually beneficial cooperation

Finland, China to deepen mutually beneficial cooperation

Show More

Video Stories

YouTube video thumbnail: What's in the India-EU Trade Deal?
Play
What's in the India-EU Trade Deal?
YouTube video thumbnail: US ICE Agents to Support Security at Winter Olympics
Play
US ICE Agents to Support Security at Winter Olympics
YouTube video thumbnail: At Least Three Killed in Russian Strike on Odesa as Zelenskyy Urges Speedier Diplomacy
Play
At Least Three Killed in Russian Strike on Odesa as Zelenskyy Urges Speedier Diplomacy
YouTube video thumbnail: What is the State of US–Europe Relations?
Play
What is the State of US–Europe Relations?

Video Title

Press Releases

Show More
Your brand’s story is being written — with or without you.
We’re the leading press release service for mid-sized businesses & organizations built for the AI era.
Learn more

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions